| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b15b5c5a588f6527dd22da7ab5ed716 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16622 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23428459c716dcc14fdb7a6e126727a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33dcf976a8f60a3d136353061dda6be5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ed0822a495b904c5ad912e763824ce |
| publicationDate |
2007-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7223740-B2 |
| titleOfInvention |
Vectors for enhanced expression of VEGF for atrial disease treatment |
| abstract |
The invention provides a vector which is capable of the expression of a vascular endothelial growth factor wherein the vector comprises a modified PCMV promoter. The invention further provides use of a vector which is capable of and expressing a vascular endothelial growth factor (VEGF) for the regulation of endothelial function, angiogenesis and arteriogenesis. The invention further comprises use of a vector which is capable of the expression of a vascular endothelial growth factor (VEGF) for the prophylactic treatment of arterial diseases and/or bone marrow diseases and/or neural diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014065110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10913957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185555-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2599507-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008175820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919478-B2 |
| priorityDate |
2001-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |